drugset / Trial / NCT00043758

Multicenter, Randomized, Double-Blind, Placebo Controlled, Efficacy Study on the Effects of Tolvaptan on Left Ventricular Dilatation in Congestive Heart Failure Patients

NCT00043758 ↗

RandomizedParallel-groupDouble-blindTreatment

Summary

The purpose of this study is to study the effects of tolvaptan on the size and function of the left heart chamber (ventricle) in patients with congestive heart failure (CHF)

Timeline

Start
2002-07
Primary completion
—
Completion
2004-07

Outcome

Missed primary endpoint

paper the between-group difference was not significant (p = 0.21). PMID 17543634 ↗

Drugs

EvaluationDrugModalityDoseRoute
Subject Tolvaptan Unknown 30 mg Oral